Anika Therapeutics Announces Exclusive U.S. Distribution Agreement for Elevess Injectable Dermal...

Tuesday July 8, 7:15 am ET Anika's HA-based Dermal Filler Incorporating Lidocaine to be Distributed by Artes Medical BEDFORD, Mass.--(BUSINESS WIRE)--Anika Therapeutics, Inc. (NASDAQ:ANIK - News), a leader in products for tissue protection, healing and repair based on hyaluronic acid (HA) technology, announced today that it has signed an exclusive agreement with Artes Medical, Inc. (NASDAQ:ARTE - News ), a medical aesthetics company, to distribute and market ELEVESS™, Anika’s cross-linked hyaluronic acid-based (HA) injectable dermal filler. ELEVESS is an injectable filler that reduces the appearance of facial wrinkles and folds such as nasolabial folds, and is the first HA-based dermal filler approved by the Food and Drug Administration (“FDA”) to incorporate the anesthetic lidocaine to improve patient comfort. Artes Medical... [read full story]                    

Add Comment
There are also 10 related articles
View all news articles about*:
*Newstin tag cloud displays all featured persons, associated organizations, related topics, regions and companies